Registry
Module Specifications
Archived Version 2023 - 2024
| |||||||||||||||||||||||||||||||||||||
|
Description | |||||||||||||||||||||||||||||||||||||
|
Learning Outcomes 1. Value why lipids and extracellular vesicles are considered a new platform for drug delivery, biomarker discovery and future cancer therapies. 2. Describe the functional characteristics of human pancreatic beta cells and evaluate the most promising sources of new beta cells for functional replacement in Type 1 diabetes. 3. Discuss the advancement in proteomic/mass spec methods to detect specific proteins in biological samples 4. Define the molecules, cell types and pathways that uniquely distinguish the cells in the body including those of the immune system 5. Knowledge of molecular, genomic and cellular processes of immunological and cancer diseases 6. Identify and discuss the cell dysregulations that lead to the hallmarks of cancer | |||||||||||||||||||||||||||||||||||||
All module information is indicative and subject to change. For further information,students are advised to refer to the University's Marks and Standards and Programme Specific Regulations at: http://www.dcu.ie/registry/examinations/index.shtml |
|||||||||||||||||||||||||||||||||||||
|
Indicative Content and
Learning Activities None | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
|
Indicative Reading List | |||||||||||||||||||||||||||||||||||||
|
Other Resources None | |||||||||||||||||||||||||||||||||||||
| Programme or List of Programmes | |||||||||||||||||||||||||||||||||||||
| Archives: |
| ||||||||||||||||||||||||||||||||||||